Literature DB >> 16880083

Accelerated atheroma in the antiphospholipid syndrome.

Eiji Matsuura1, Kazuko Kobayashi, Masako Tabuchi, Luis R Lopez.   

Abstract

Increased cardiovascular morbidity and mortality due to the pre-mature or accelerated development of atherosclerosis has been reported in patients with systemic autoimmune diseases such as systemic lupus erythematosus. These findings motivated a great deal of research into the role of autoimmunity in atherogenesis. The relationship between atherosclerosis and cholesterol metabolism to atherosclerosis has been well established. However, the participation of newer inflammatory and immunologic mechanisms are emerging as relevant factors for the initiation and progression of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880083     DOI: 10.1016/j.rdc.2006.05.006

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

Review 1.  Atherogenesis and the humoral immune response to modified lipoproteins.

Authors:  Gabriel Virella; Maria F Lopes-Virella
Journal:  Atherosclerosis       Date:  2008-04-12       Impact factor: 5.162

Review 2.  Atherosclerosis in autoimmune diseases.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Luis R Lopez
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

3.  Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome.

Authors:  Geoffrey Urbanski; Antoine Caillon; Caroline Poli; Gilles Kauffenstein; Marc-Antoine Begorre; Laurent Loufrani; Daniel Henrion; Cristina Belizna
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.